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Abstract
Background: weak grip strength (GS) and chronic inflammation have been implicated in the aetiology of sarcopenia in old-
er adults. Given the interrelationships between inflammatory biomarkers, a summary variable may provide better insight
into the relationship between inflammation and muscle strength. This approach has not been investigated in very old adults
(aged ≥85) who are at highest risk of muscle weakness.
Methods: we used mixed models to explore the prospective association between GS over 5 years in 845 participants in the
Newcastle 85+ Study, and inflammatory components identified by principal component analysis (PCA). Cut-offs of ≤27 kg
(men) and ≤16 (women) were used to define sub-cohorts with weak and normal GS at each assessment.
Results: PCA identified three components, which explained 70% of the total variance in seven baseline biomarkers. Basal
interleukin-6 (IL-6) and tumour necrosis factor (TNF-α) had the highest loadings on Component 1; stimulated IL-6 and
TNF-α and homocysteine the highest on Component 2; high-sensitivity C-reactive protein (hsCRP) loaded positively and
albumin negatively to Component 3. In adjusted mixed models, only Component 3 was associated with GS. One SD
increase of Component 3 was associated with a 0.41 kg lower GS initially (P = 0.03) in all participants, but not with GS
decline over time. Similar conclusions held for those in the weak and normal GS sub-cohorts.
Conclusion: an inflammatory profile including hsCRP and albumin was independently associated with baseline GS. Future
studies linking inflammatory profiles and muscle strength are needed to corroborate these findings in older adults.
Keywords: older adults, cohort study, risk factor, grip strength, inflammatory biomarker, principal component analysis
Introduction
Weak grip strength (GS)—an indicator of upper-body and
overall muscle strength decline [1], has been recognised as a
powerful predictor of multi-morbidity [2], disability [3] and
mortality [4], and is a key component of frailty [5] and sar-
copenia [1, 6] in young old (aged ≥65) and very old adults
(aged ≥85). Because of the increasing public health burden
associated with low muscle strength and poor physical func-
tioning [7], it is important to identify risk factors and bio-
logical mechanisms that underlie the relationship between
advancing age and decline in muscle strength.
A number of studies have demonstrated the role of
chronic, low-grade inflammation in muscle strength decline
[8]. An imbalance between pro- and anti-inflammatory bio-
markers has been suggested to contribute to a detrimental
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catabolic effect of inflammation on aged myofibres, in the
absence of an acute inflammatory response [9].
Both cross-sectional and longitudinal studies have shown
the relationship between lower muscle strength and decline
with higher plasma concentration of interleukin-6 (IL-6) and
tumour necrosis factor alpha (TNF-α) and C-reactive protein
(hsCRP) which were analysed either separately [10–15], or in
combination [9, 16], or as a part of summary variable derived
statistically to characterise inflammatory profile [17–19].
Assessing these biomarkers individually in relation to muscle
strength and physical performance decline has been the com-
monest approach. For example, higher baseline concentra-
tions of TNF-α were associated with a greater 5-year decline
in GS and knee extensor strength in the Health, Aging and
Body Composition (Health ABC) study of over 2000 partici-
pant aged 70–79 [10]. An increase in IL-6 concentration was
associated with GS decline over 9 years in 901 participants in
the Cardiovascular Health Study All Stars aged 85 at follow-
up, irrespective of other relevant biological factors [16].
A few studies have gone further and taken into consider-
ation the complexity of the inflammatory response and inter-
dependence of individual inflammatory biomarkers. They have
used multiple measures of inflammation to investigate the rela-
tionship between a summary variable [e.g. inflammatory index
or components derived by principal component analysis
(PCA)] and muscle strength. However, the results have been
contradictory. In the Health ABC study, TNF-α and CRP-
related components (derived by PCA from 8 inflammatory
biomarkers) were inversely associated with GS [19], but higher
inflammatory index (a combination of gender-adjusted tertiles
of IL-6 and TNF-α) was not associated with worse GS and
physical performance in older adults aged ≥80 living in
Belgium [18]. Furthermore, little is known about the prospect-
ive inflammation–muscle strength relationship in the very old,
who are at the highest risk of low muscle strength as well as
subclinical inflammation [20].
Therefore, the aim of this study was to (i) identify
inflammatory components from seven inflammatory bio-
markers using PCA and (ii) investigate the association
between identified components and change in GS over 5
years in the very old.
Methods
Study cohort
We included 845 participants from the Newcastle 85+
Study, a longitudinal study of individuals born in 1921
[mean age 85.49 (SD) = 0.44 years at baseline in 2006/07],
and residing in Newcastle and North Tyneside region,
United Kingdom, as described previously [21, 22]. Participants
were followed up over 5 years from baseline [i.e. 1.5- (wave 2),
3- (wave 3) and 5-year follow-up (wave 4)]. At baseline, 813
(96.2%) participants had valid GS measurement, followed by
605 (71.6%) at wave 2, 452 (53.5%) at wave 3 and 294
(34.8%) at wave 4. Complete (baseline) data on 7 inflammatory
biomarkers was available for 724 (85.7%) participants. The
study was approved by the Newcastle and North Tyneside
Local Research Ethics Committee One.
Inflammatory biomarkers
Details about biomarker methodology, measurement and
characteristics have been reported previously [20] (see
Supplementary data, Appendix 1, available at Age and Ageing
online). We included the following blood-based inflamma-
tory biomarkers reported in the literature to be relevant for
GS in later life: IL-6 (basal and stimulated; pg/mL), TNF-α
(basal and stimulated; pg/mL), hsCRP (mg/L), homocyst-
eine (HCY) (μmol/L) and albumin (g/L). All biomarkers
except albumin were non-normally distributed, and were
categorised in deciles to correct for marked positive skew.
Albumin was divided in sextiles as the highest possible cat-
egorisation because of data granularity. Median and ranges
of selected biomarkers are described in Supplementary data,
Table S1, available at Age and Ageing online.
GS measurement
GS was measured using a standardised protocol in standing
position with a Takei hand dynamometer (Model A5401
digital 0–100 kg; Takei Scientific Instruments Co., Ltd.,
Niigata City, Japan) as described previously [23]. Two alter-
nate measurements (in kg) for each hand were recorded,
and the mean (M, SD) of four measurements for each par-
ticipant for each wave was calculated [24]. GS data was nor-
mally distributed across the waves and was used as
continuous variable in subsequent analyses.
Other measures and potential confounders
Confounders for multivariable analysis included a set of socio-
demographic, anthropometric, lifestyle and health-related factors
previously determined to be associated with initial level and rate
of change in GS in this [23] and other cohorts. All confounders
and descriptive variables are defined in Supplementary data,
Appendix 1, are available at Age Ageing online. The sociodemo-
graphic covariate was sex. Anthropometry included height, BMI
and fat-free mass (FFM). Lifestyle included self-reported phys-
ical activity, and health-related variables comprised self-rated
health, presence of depressive symptoms, multi-morbidity, arth-
ritis in hands and intake of non-steroidal anti-inflammatory
drugs [22]. To account for losses to follow-up (mostly death
and withdrawal) over 5 years, we included an attrition variable
(completed the study/dropped out) in the analyses of change
[25]. All confounders were assessed at baseline, and height and
FFM were centred to sex-specific mean.
We used cut-offs of ≤27 kg (men) and ≤16 kg (women),
a strength of T-score ≤2.5 below sex-specific peak mean at
age of 32 [26] to define a weak versus normal GS at baseline
and follow-up, and to distinguish between the ‘weak’ and
‘normal’ GS sub-cohorts in longitudinal analysis of change in
GS (for details see Supplementary data, Appendix 1, available
at Age and Ageing online). We identified 1,607 weak and 557
normal GS observations over the study period.
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For Statistics and sensitivity analysis, Supplementary
data, Appendix 2, are available in Age and Ageing online.
Results
Inflammatory components
Biomarker descriptive statistics (median and range) and
Spearman correlation coefficients (r) among pairs of seven
inflammatory biomarkers are presented in Supplementary
data, Table S1 and Table S2, are available in Age and Ageing
online. Highest correlation (r ≥ 0.71) was observed between
cytokines IL-6 and TNF-α (both basal and stimulated).
PCA with inflammatory biomarkers derived three compo-
nents which explained 70% of the variance in the inflammatory
variables: 34.9% (Component 1), 19.6% (Component 2) and
15.6% (Component 3) (Table 1). Communality coefficients
were highest for basal IL-6 and basal TNF-α (0.86) which
loaded the highest on Component 1 (‘Basal cytokines-related
component’). Stimulated TNF-α, stimulated IL-6, and HCY
loaded highest on Component 2 (‘Stimulated cytokines-related
component’) and hsCRP and albumin loaded the highest onto
Component 3 (‘hsCRP-related component’).
Characteristics of participants by inflammatory
components
Raw GS data by tertiles of each inflammatory component
across four waves, and baseline characteristics of partici-
pants by these tertiles are shown in Supplementary data,
Table S3 and Table S4, are available in Age and Ageing
online. Participants in Component 3 (‘hsCRP-related com-
ponent’) differed significantly on key health and lifestyle
characteristics across the tertiles. Specifically, participants
in the highest tertile were the most likely to have fair/
poor health (P < 0.001), to be obese (P = 0.001), the least
physically active (P < 0.001), to have depressive symp-
toms (P = 0.001), dementia (P = 0.007), cardiovascular
diseases (P = 0.006), metabolic syndrome (P = 0.02), the
highest total cholesterol/HDL ratio (P < 0.001), and not to
complete the study (P < 0.001) compared with participants
in other tertiles.
GS trajectories by inflammatory components
Significant associations with GS were found only for
Component 3 (hsCRP-related component). Table 2 shows
multivariable adjusted β coefficients (fixed effects) of
Component 3 on GS initially, and the main effect of time
on GS decline in the presence of important confounders
and time × covariate interaction terms. In all models we
observed a significant linear decline in GS of approximately
−0.7 to 1 kg (entire cohort), −0.5 kg (normal GS sub-
cohort) and −0.5 to −0.8 kg (weak GS sub-cohort) per year
(all P ≤ 0.002). In Model 1, 1 SD increase in Component 3
score was associated with −1.05, −1.02 and −0.51 kg weak-
er GS (all P < 0.001) in the entire cohort, normal and weak
GS sub-cohort, respectively. In Model 2, additional adjust-
ment for important confounders and interaction terms atte-
nuated the associations, but they remained significant in all
groups. In Model 3, the association was sustained only in
the normal GS sub-cohort after the inclusion of the attri-
tion variable: 1 SD increase in Component 3 score was
associated with −0.51 kg lower initial GS (P = 0.02).
However, Component 3 was not associated with the rate of
decline (slope) in GS over 5 years (data not shown).
For the results for sensitivity analysis, Supplementary
data, Appendix 3, are available at Age and Ageing online.
Discussion
To the best of our knowledge, this is the first prospective
evaluation of the relationship between summary variables
of inflammation (produced by PCA) and GS decline in the
very old (aged ≥85). Utilising data from the Newcastle 85+
Study, we found that three components could be used to
summarise 7 inflammatory biomarkers (basal and stimu-
lated IL-6 and TNF-α in PBMC, hsCRP, HCY and albu-
min) previously identified in the literature to be associated
with low muscle strength (GS) in older adults. Only
Component 3 (‘hsCRP-related component’) was inversely
associated with GS initially but not with 5-year GS decline
after adjustment for important confounders. The results sug-
gest a role of the hsCRP-related but not the cytokine-related
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Principal components statistics (eigenvalues, communalities and rotated component loadings)a for three inflamma-
tory components in the very old
Component Eigenvalues % Of variance Biomarker Communalities Rotated component loadings
% Total variance Component 1 Component 2 Component 3
Component 1 2.44 34.85 IL-6 stimulated 0.78 0.85
Component 2 1.37 19.57 TNF-α stimulated 0.82 0.85
Component 3 1.09 15.63 IL-6 basal 0.86 0.92




IL-6, interleukin-6; TNF-α, tumour necrosis factor alpha; hsCRP, high-sensitivity C-reactive protein; HCY, homocysteine.
aPrincipal component analysis and orthogonal varimax rotation with Kaiser normalisation. A scree plot confirmed the presence of three independent inflammatory
components. Loadings > 0.4 were used to identify biomarkers contributing to a component. Lower loadings were not reported.
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inflammatory component for muscle strength in very old
adults.
Most studies to date have assessed the relationship
between inflammation and physical performance in older
adults using an individual biomarkers approach. They have
reported an inverse association between baseline hsCRP,
IL-6 and TNF-α (from serum or plasma) and muscle
strength (GS) [11–15], and some evidence for their involve-
ment in GS decline over time [9, 10, 12, 16]. A few con-
sidered alternative methods to create a latent variable or
inflammatory index from multiple inflammatory biomarkers
to account for their interrelationship [18, 19]. Only two
included adults aged 80 and over, but reported conflicting
results [15, 18]. Comparison between the studies employing
an inflammatory profile approach in relation to muscle
strength is difficult because of the differences in biomarker
selection, methods used to derive summary measure of
inflammation, physical performance tests used, and the
population included. We are aware of only one study
(Health ABC) that used PCA to create inflammatory
components, and explored their cross-sectional relationship
with muscle strength in older adults aged 70–79 [19]. A
CRP-related component (characterised by the highest load-
ing of serum CRP, IL-6 and plasminogen activator inhibi-
tor-1) was associated with lower GS after adjustment for
important confounders. Using a similar approach, we have
also found the strongest association with a hsCRP-
dominated component (Component 3) and worse initial GS
(but not GS decline) in very old adults, particularly in those
who maintained normal GS over 5 years [>27 kg (men),
>16 kg (women)]. No association was found between
cytokine-related components and GS, which could be
attributed to the source of cytokines and the type of inflam-
mation. Whilst other studies measured Il-6 and TNF-α in
serum or plasma (systemic inflammation), we measured
cytokines released from PBMC (either under no stimulation
or following the cells activation). The negative results may
suggest that in comparison with the more robust markers
of chronic inflammation (Component 3), PBMC-released
cytokines (Component 1) and the ability of PBMC to
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Multivariable adjusted β-coefficients of growth curve models for GS by Component 3 (hsCRP-related) over 5 years
in the very old
Effects Multivariable adjusted
Model 1 Model 2 Model 3
β (SE)a P β (SE) P β (SE) P
Entire cohort
GS initial status
Intercept 17.76 (0.29) <0.001 10.68 (0.70) <0.001 10.49 (0.70) <0.001
Component 3b −1.05 (0.28) <0.001 −0.41 (0.19) 0.03 −0.35 (0.19) 0.06
Declinec
Time −0.65 (0.14) <0.001 −0.96 (0.20) <0.001 −0.98 (0.20) <0.001
Time2 −0.03 (0.03) 0.28 −0.30 (0.03) 0.26 −0.03 (0.03) 0.27
Normal GS sub-cohortd
GS initial status
Intercept 24.39 (0.46) <0.001 16.39 (0.82) <0.001 16.36 (0.83) <0.001
Component 3b −1.02 (0.47) 0.03 −0.51 (021) 0.02 −0.51 (0.21) 0.02
Declinec
Time −0.47 (0.08) <0.001 −0.45 (0.071) <0.001 −0.45 (0.07) <0.001
Weak GS sub-cohortd
GS initial status
Intercept 15.41 (0.26) < 0.001 10.70 (0.62) <0.001 10.57 (0.62) <0.001
Component 3b −0.51 (0.24) 0.04 −0.31 (0.15) 0.03 −0.26 (0.15) 0.08
Declinec
Time −0.52 (0.17) 0.002 −0.76 (0.22) 0.001 −0.78 (0.22) 0.001
Time2 −0.02 (0.03) 0.14 −0.05 (0.03) 0.14 −0.05 (0.03) 0.14
FFM, fat-free mass; GS, grip strength; hsCRP, high-sensitivity C-reactive protein.
aβ-coefficients (SE) are estimates of fixed effects using longitudinal grip strength data, and assess population averages in GS.
bFixed effect of covariate estimated initial level and trajectory differences in GS as a function of the covariate.
cThe main effect of time (i.e. Time and Time2) tested linear and non-linear change in GS across population over 5 years. Random effects included both intercept
and slopes (linear change).
dWeak GS was defined as having a strength ≤27 kg in men, and ≤16 kg in women. This cut-off was used to identify participants with weak and normal GS across
4 measurements.
Model 1 includes a linear and quadratic trend of time (except in normal GS sub-cohort), and Component 3.
Model 2 is additionally adjusted for:
Entire cohort: sex, self-rated heath, anthropometry (height, FFM), physical activity, multi-morbidity and interaction terms (time × sex, time × physical activity).
Normal grip strength sub-cohort: sex, marital status, height, depressive symptoms and physical activity.
Weak grip strength sub-cohort: the same covariates and interaction terms as the entire cohort and for BMI (instead of FFM).
Model 3 is additionally adjusted for attrition variable.
The models include only significant predictors at first entry.
A. Granic et al.
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mount a response against infection (Component 2), play no
or only a limited role in influencing muscle strength (GS) in
very old adults.
Although data reduction analyses such as PCA makes
no prior assumptions about the biological mechanisms
underlying inflammation–muscle strength relationships, they
may detect potentially unexplored interactions between bio-
markers relevant for overall [27] and muscle health.
Because we detected little or no association between indi-
vidual biomarkers and GS prior to PCA (data not shown),
the PCA approach may have strengthened the association
between inflammation and muscle strength compared with
an individual biomarker approach. However this needs to
be confirmed in other studies involving the very old.
Component 3 was characterised by two dominant bipo-
lar eigenvectors: (i) hsCRP, an acute phase protein produced
by liver in response to elevated IL-6, has been the most
consistently recognised predictor of cardiovascular events in
several population-based studies [8] and (ii) (serum) albu-
min, a negative acute phase reactant, which decreases in
older adults because of its increased catabolism and
decreased synthesis during inflammation and malnutrition
[28]. A synergistic and cumulative effect of these biomar-
kers may have exacerbated pathways contributing to greater
muscle catabolism and reduced myogenesis [29], increased
vascular pathology [8] and frailty [27]. Participants with
higher levels of Component 3 had poorer health, and were
more likely to drop out of the study, which may have
underestimated the associations. Also, we did not detect
any association between Component 3 and GS decline pos-
sibly because of loss of power in the data, and selection
bias of very old ‘survivors’.
Study limitations and strengths
This study has several limitations: (i) the results are obser-
vational and do not imply causality, and are affected by the
choice of biomarkers used in PCA; (ii) the number of
selected biomarkers was small, thus the results are not
definitive and need to be repeated in other studies involving
the very old; (iii) other biological mechanisms (e.g. oxida-
tion) and biomarkers (e.g. cytokine receptors) may contrib-
ute to muscle strength decline, and uncontrolled factors
may still explain the inflammation-GS relationship (e.g. mal-
nutrition, medication duration and dosage); (iv) limited
comparison with other studies, because we used PBMC-
released cytokines; (v) inflammatory biomarkers at baseline
may be poor predictors of change in GS; (vi) PCA is an
exploratory technique, thus the utility of the individual bio-
marker approach should still be recognised; and (vii) limited
generalisability of the results to the wider very old popula-
tion. The strengths of the study include: (i) its prospective
design, (ii) the novelty and robustness of the PCA approach
in deriving inflammatory profiles, (iii) representativeness of
the UK population and (iv) adjustment for several factors
associated with muscle strength and inflammation.
Future directions
We have provided preliminary evidence for the utility of the
PCA approach in deriving inflammatory profiles from a set
of inflammatory biomarkers to explore their relationship
with muscle function in the very old. This approach and
the results need to be corroborated in other prospective
studies of older adults and should include a wider range of
inflammatory biomarkers relevant for muscle function in
later life [27].
In conclusion, we have identified three inflammatory
biomarker profiles but only the one including hsCRP and
albumin showed an association with baseline GS independ-
ent of key risk factors. These findings need to be corrobo-
rated in future studies involving the very old.
Key points
• We have investigated a summary measure of inflammation
(produced by PCA) in relation to GS decline in very old
adults.
• We identified three inflammatory biomarker profiles but
only the one including hsCRP and albumin was related to
baseline GS.
• Future studies linking inflammatory profiles and muscle
strength are needed to corroborate these findings in older
adults.
Supplementary data
Supplementary data mentioned in the text are available to
subscribers in Age and Ageing online.
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